Prism Pharmaceuticals, Inc. is a US-based, acute care specialty pharmaceutical company developing and commercializing branded cardiovascular injectable products. Prism is preparing to launch its first product, NEXTERONE® (amiodarone HCl) Injection, from a portfolio that addresses current unmet medical needs with a specific focus on medication safety in the hospital environment.